CONVIVO Endomicroscopy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

October 12, 2024

Study Completion Date

October 12, 2024

Conditions
Brain Tumor
Interventions
DEVICE

CONVIVO

Any clinical adverse event (AE), laboratory abnormality, or other medical condition or situation occurs such that continued participation in the study would not be in the best interest of the participant. The participant meets an exclusion criterion (either newly developed or not previously recognized) that precludes further study participation.

Trial Locations (1)

11030

RECRUITING

Northwell Health, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER